SCHEMBL33264

SCHEMBL33264

Cc1nc2ccc(Cl)cc2s1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.61
NPC1 O15118 5/20 0.57
RAB9A P51151 5/20 0.57
ALDH1A1 P00352 4/20 0.57
MAPT P10636 2/20 0.57
TP53 P04637 1/20 0.57
PKM P14618 1/20 0.57
HPGD P15428 1/20 0.57
HSD17B10 Q99714 1/20 0.57
HTT P42858 3/20 0.56
KDM4E B2RXH2 3/20 0.56
GAA P10253 2/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
LMNA P02545 1/20 0.56
ALOX12 P18054 1/20 0.56
TDP1 Q9NUW8 2/20 0.53
DYRK1A Q13627 1/20 0.53
FSCN1 Q16658 1/20 0.53
CASP3 P42574 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29361355 0.84 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9AALDH1A1MAPT
SCHEMBL1049510 0.84 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9AALDH1A1MAPT
SCHEMBL334252 0.81 NPC1 (0.61) SMN1; SMN2NPC1RAB9AALDH1A1MAPT
Iodomethane SCHEMBL28083731 0.81 SMN1; SMN2 (0.57) SMN1; SMN2NPC1RAB9AALDH1A1MAPT
SCHEMBL2186277 0.80 SMN1; SMN2 (0.53) SMN1; SMN2NPC1RAB9AALDH1A1MAPT
Propane SCHEMBL28083723 0.79 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9AALDH1A1MAPT
SCHEMBL30542465 0.79 SMN1; SMN2 (0.66) SMN1; SMN2NPC1RAB9AALDH1A1MAPT
SCHEMBL84327 0.79 SMN1; SMN2 (0.66) SMN1; SMN2NPC1RAB9AALDH1A1MAPT
SCHEMBL2170235 0.78 SMN1; SMN2 (0.54) SMN1; SMN2NPC1RAB9AALDH1A1MAPT
SCHEMBL1639542 0.78 NPC1 (0.58) SMN1; SMN2NPC1RAB9AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 288 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104419326-A Slurry composition for chemical mechanical polishing COWON INNOTECH INC 2015-03-18 CN claimed
CN-115819371-B Preparation method of benzothiazole-2-formaldehyde and derivatives thereof 新疆师范大学 2024-05-14 CN disclosed
CN-117658945-A Synthesis method of persulfate-induced alkylation modified nitrogen heterocyclic compound 浙江工业大学 2024-03-08 CN disclosed
US-20230303522-A1 ARYLTETRAHYDROPYRIDAZINE DERIVATIVE OR SALT THEREOF, INSECTICIDAL AGENT CONTAINING THE COMPOUND, AND METHOD OF USE THEREOF NIHON NOHYAKU CO., LTD. (JP) 2023-09-28 US disclosed
US-20230303522-A1 ARYLTETRAHYDROPYRIDAZINE DERIVATIVE OR SALT THEREOF, INSECTICIDAL AGENT CONTAINING THE COMPOUND, AND METHOD OF USE THEREOF NIHON NOHYAKU CO., LTD. (JP) 2023-09-28 US disclosed
EP-4190784-A1 NITROGEN-CONTAINING FUSED RING DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Hansoh Biomedical Co., Ltd. (CN) 2023-06-07 EP disclosed
WO-2023076237-A1 COMPOUNDS AS GLP-1R AGONISTS TERNS PHARMACEUTICALS, INC. (US) 2023-05-04 WO disclosed
EP-4174057-A1 ARYLTETRAHYDROPYRIDAZINE DERIVATIVE OR SALT THEREOF, INSECTICIDE COMPRISING SAID COMPOUND, AND METHOD FOR USING SAID INSECTICIDE Nihon Nohyaku Co., Ltd. (JP) 2023-05-03 EP disclosed
CN-115819371-A Preparation method of benzothiazole-2-formaldehyde and derivatives thereof 新疆师范大学 2023-03-21 CN disclosed
CN-109265409-B Synthesis method of 2-substituted benzoxazole, 2-substituted benzothiazole and derivatives thereof 重庆医科大学 2022-09-02 CN disclosed
EP-1394162-A1 Intermediates of azole antifungal agents and processes for the preparation thereof Eisai Co., Ltd. (JP) 2004-03-03 EP disclosed
EP-1394142-A1 Carboxylic acid intermediates of antifungal agents and processes for the preparation thereof Eisai Co., Ltd. (JP) 2004-03-03 EP disclosed
EP-1231210-A2 Azole antifungal agents, processes for the preparation thereof, and intermediates Eisai Co., Ltd. (JP) 2002-08-14 EP disclosed
US-5792781-A EFFECTIVE AGAINST DERMATOMYCOSIS/VISCEROMYCOSIS CAUSED BY FUNGI, I.E., CANDIDA ALBICANS EISAI CO., LTD. (JP) 1998-08-11 US disclosed
US-5789429-A FUNGICIDE EISAI CO., LTD. (JP) 1998-08-04 US disclosed
US-5648372-A TRIAZOLES EISAI CO., LTD. (JP) 1997-07-15 US disclosed
EP-0667346-A2 Azole antifungal agents, process for the preparation there of and intermediates Eisai Co., Ltd. (JP) 1995-08-16 EP disclosed
EP-0214423-B1 PROCESS FOR THE PREPARATION OF 2-SUBSTITUTED BENZOTHIAZOLES HOECHST AKTIENGESELLSCHAFT (DE) 1990-01-03 EP disclosed
US-4727154-A ACRYLATION 2-MERCAPTOPHENYLUREA HOECHST AKTIENGESELLSCHAFT 1988-02-23 US disclosed
EP-0214423-A1 Process for the preparation of 2-substituted benzothiazoles HOECHST AKTIENGESELLSCHAFT (DE) 1987-03-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303522-A1 ARYLTETRAHYDROPYRIDAZINE DERIVATIVE OR SALT THEREOF, INSECTICIDAL AGENT CONTAINING THE COMPOUND, AND METHOD OF USE THEREOF CYP4Z1, DDT, AADAC SMN1; SMN2 4280/4885NPC1 2798/4885RAB9A 2642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.